{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:32:47Z","timestamp":1791232367744,"version":"4.1.0"},"reference-count":69,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,4,9]],"date-time":"2015-04-09T00:00:00Z","timestamp":1428537600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100000947","name":"Australian Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001047","name":"Ian Potter Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001171","name":"Cancer Institute NSW","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001544","name":"Children's Medical Research Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001544","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Newcastle Innovation"},{"DOI":"10.13039\/501100001168","name":"Queensland Cancer Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001168","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Ramaciotti Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Traffic"],"published-print":{"date-parts":[[2015,6]]},"abstract":"<jats:p>\n                    Chlorpromazine is a phenothiazine\u2010derived antipsychotic drug (\n                    <jats:styled-content style=\"fixed-case\">APD<\/jats:styled-content>\n                    ) that inhibits clathrin\u2010mediated endocytosis (\n                    <jats:styled-content style=\"fixed-case\">CME<\/jats:styled-content>\n                    ) in cells by an unknown mechanism. We examined whether its action and that of other\n                    <jats:styled-content style=\"fixed-case\">APDs<\/jats:styled-content>\n                    might be mediated by the\n                    <jats:styled-content style=\"fixed-case\">GTPase<\/jats:styled-content>\n                    activity of dynamin. Eight of eight phenothiazine\u2010derived\n                    <jats:styled-content style=\"fixed-case\">APDs<\/jats:styled-content>\n                    inhibited dynamin I (\n                    <jats:styled-content style=\"fixed-case\">dynI<\/jats:styled-content>\n                    ) in the 2\u201312 \u00b5\n                    <jats:sc>m<\/jats:sc>\n                    range, the most potent being trifluoperazine (\n                    <jats:styled-content style=\"fixed-case\">\n                      IC\n                      <jats:sub>50<\/jats:sub>\n                    <\/jats:styled-content>\n                    2.6 \u00b1 0.7 \u00b5\n                    <jats:sc>m<\/jats:sc>\n                    ). They also inhibited dynamin\n                    <jats:styled-content style=\"fixed-case\">II<\/jats:styled-content>\n                    (\n                    <jats:styled-content style=\"fixed-case\">dynII<\/jats:styled-content>\n                    ) at similar concentrations. Typical and atypical\n                    <jats:styled-content style=\"fixed-case\">APDs<\/jats:styled-content>\n                    not based on the phenothiazine scaffold were 8\u2010 to 10\u2010fold less potent (haloperidol and clozapine) or were inactive (droperidol, olanzapine and risperidone). Kinetic analysis showed that phenothiazine\u2010derived\n                    <jats:styled-content style=\"fixed-case\">APDs<\/jats:styled-content>\n                    were lipid competitive, while haloperidol was uncompetitive with lipid. Accordingly, phenothiazine\u2010derived APDs inhibited\n                    <jats:styled-content style=\"fixed-case\">dynI GTPase<\/jats:styled-content>\n                    activity stimulated by lipids but not by various\n                    <jats:styled-content style=\"fixed-case\">SH3<\/jats:styled-content>\n                    domains. All dynamin\u2010active\n                    <jats:styled-content style=\"fixed-case\">APDs<\/jats:styled-content>\n                    also inhibited transferrin (Tfn)\n                    <jats:styled-content style=\"fixed-case\">CME<\/jats:styled-content>\n                    in cells at related potencies. Structure\u2013activity relationships (\n                    <jats:styled-content style=\"fixed-case\">SAR<\/jats:styled-content>\n                    ) revealed dynamin inhibition to be conferred by a substituent group containing a terminal tertiary amino group at the\n                    <jats:styled-content style=\"fixed-case\">N2<\/jats:styled-content>\n                    position. Chlorpromazine was previously proposed to target\n                    <jats:styled-content style=\"fixed-case\">AP<\/jats:styled-content>\n                    \u20102 recruitment in the formation of clathrin\u2010coated vesicles (\n                    <jats:styled-content style=\"fixed-case\">CCV<\/jats:styled-content>\n                    ). However, neither chlorpromazine nor thioridazine affected\n                    <jats:styled-content style=\"fixed-case\">AP<\/jats:styled-content>\n                    \u20102 interaction with amphiphysin or clathrin. Super\u2010resolution microscopy revealed that chlorpromazine blocks neither clathrin recruitment by\n                    <jats:styled-content style=\"fixed-case\">AP<\/jats:styled-content>\n                    \u20102, nor\n                    <jats:styled-content style=\"fixed-case\">AP<\/jats:styled-content>\n                    \u20102 recruitment, showing that\n                    <jats:styled-content style=\"fixed-case\">CME<\/jats:styled-content>\n                    inhibition occurs downstream of\n                    <jats:styled-content style=\"fixed-case\">CCV<\/jats:styled-content>\n                    formation. Overall, potent dynamin inhibition is a shared characteristic of phenothiazine\u2010derived\n                    <jats:styled-content style=\"fixed-case\">APDs<\/jats:styled-content>\n                    , but not other typical or atypical\n                    <jats:styled-content style=\"fixed-case\">APDs<\/jats:styled-content>\n                    , and the data indicate that dynamin is their likely in\u2010cell target in endocytosis.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:inline-graphic xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"graphic\/tra12272-gra-0001.png\" xlink:title=\"image\"\/>\n                  <\/jats:p>","DOI":"10.1111\/tra.12272","type":"journal-article","created":{"date-parts":[[2015,2,18]],"date-time":"2015-02-18T02:53:18Z","timestamp":1424227998000},"page":"635-654","source":"Crossref","is-referenced-by-count":168,"title":["Phenothiazine\u2010Derived Antipsychotic Drugs Inhibit Dynamin and Clathrin\u2010Mediated Endocytosis"],"prefix":"10.1111","volume":"16","author":[{"given":"James A.","family":"Daniel","sequence":"first","affiliation":[{"name":"Cell Signalling Unit, Children's Medical Research Institute The University of Sydney  Sydney NSW 2145 Australia"},{"name":"Present address: Department of Molecular Neurobiology, Max Planck Institute of Experimental Medicine  Hermann\u2010Rein\u2010Str. 3 37075 G\u00f6ttingen Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ngoc","family":"Chau","sequence":"additional","affiliation":[{"name":"Cell Signalling Unit, Children's Medical Research Institute The University of Sydney  Sydney NSW 2145 Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed K.","family":"Abdel\u2010Hamid","sequence":"additional","affiliation":[{"name":"Centre for Chemical Biology, Chemistry The University of Newcastle  Callaghan NSW 2308 Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingbo","family":"Hu","sequence":"additional","affiliation":[{"name":"Epithelial Cancer Group, The University of Queensland Diamantina Institute, Translational Research Institute University of Queensland  Woolloongabba QLD 4102 Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"von Kleist","sequence":"additional","affiliation":[{"name":"Leibniz Institut f\u00fcr Molekulare Pharmakologie &amp; Freie Universit\u00e4t Berlin  13125 Berlin Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ainslie","family":"Whiting","sequence":"additional","affiliation":[{"name":"Cell Signalling Unit, Children's Medical Research Institute The University of Sydney  Sydney NSW 2145 Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai","family":"Krishnan","sequence":"additional","affiliation":[{"name":"Cell Signalling Unit, Children's Medical Research Institute The University of Sydney  Sydney NSW 2145 Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Maamary","sequence":"additional","affiliation":[{"name":"Cell Signalling Unit, Children's Medical Research Institute The University of Sydney  Sydney NSW 2145 Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon R.","family":"Joseph","sequence":"additional","affiliation":[{"name":"Epithelial Cancer Group, The University of Queensland Diamantina Institute, Translational Research Institute University of Queensland  Woolloongabba QLD 4102 Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Simpson","sequence":"additional","affiliation":[{"name":"Epithelial Cancer Group, The University of Queensland Diamantina Institute, Translational Research Institute University of Queensland  Woolloongabba QLD 4102 Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Haucke","sequence":"additional","affiliation":[{"name":"Leibniz Institut f\u00fcr Molekulare Pharmakologie &amp; Freie Universit\u00e4t Berlin  13125 Berlin Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"McCluskey","sequence":"additional","affiliation":[{"name":"Centre for Chemical Biology, Chemistry The University of Newcastle  Callaghan NSW 2308 Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip J.","family":"Robinson","sequence":"additional","affiliation":[{"name":"Cell Signalling Unit, Children's Medical Research Institute The University of Sydney  Sydney NSW 2145 Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,4,9]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-050911-161504"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2005.01.003"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-25761-2_3"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-25761-2_2"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-59745-178-9_2"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044252"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.107.12.3461"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.275.9.6439"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2005.07.003"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.1041180212"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1080\/13550280152537157"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.18883-0"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.e03-12-0921"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.16.10826-10829.2005"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2005.05.006"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2008.06.004"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1018845108"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceb.2011.03.004"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.123.5.1107"},{"key":"e_1_2_7_21_1","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1016\/S0021-9258(17)35701-0","article-title":"Internalization and recycling of transferrin and its receptor. Effect of trifluoperazine on recycling in human erythroleukemic cells","volume":"261","author":"Hunt RC","year":"1986","journal-title":"J Biol Chem"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncb2473"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2012.07.024"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.144.1.31"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI111129"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M607211200"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2012.10.007"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm900036m"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2014.046"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.283879"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/tra.12119"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1021\/cb400137p"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm100442u"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm100119c"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1021\/ml200284s"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2004.03.096"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1039\/B707092F"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.107.034207"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.E04-11-1016"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1582-4934.2010.01226.x"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/nn.2355"},{"issue":"2","key":"e_1_2_7_42_1","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1042\/bj2910397","article-title":"Binding of the calcium antagonist flunarizine to phosphatidylcholine bilayers: charge effects and thermodynamics","volume":"291","author":"Thomas PG","year":"1993","journal-title":"Biochem J"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(97)00108-8"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1995.tb13236.x"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.06.025"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.049197"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.biochem.77.061906.092014"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.e09-08-0683"},{"key":"e_1_2_7_49_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1233920"},{"key":"e_1_2_7_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(74)90317-7"},{"key":"e_1_2_7_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0969-2126(02)00784-0"},{"key":"e_1_2_7_52_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1000604"},{"key":"e_1_2_7_53_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1000057"},{"key":"e_1_2_7_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.devcel.2009.11.005"},{"key":"e_1_2_7_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.devcel.2013.06.019"},{"key":"e_1_2_7_56_1","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.31.1489"},{"key":"e_1_2_7_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2009.11.067"},{"key":"e_1_2_7_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(81)91276-6"},{"key":"e_1_2_7_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2011.05.138"},{"key":"e_1_2_7_60_1","doi-asserted-by":"publisher","DOI":"10.4103\/0975-7406.80782"},{"key":"e_1_2_7_61_1","first-page":"CD002750","article-title":"Calcium antagonists as an add\u2010on therapy for drug\u2010resistant epilepsy","volume":"3","author":"Hasan M","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_7_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-6273(03)00815-8"},{"key":"e_1_2_7_63_1","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2011.123"},{"key":"e_1_2_7_64_1","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2011.43"},{"key":"e_1_2_7_65_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4001511"},{"key":"e_1_2_7_66_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4001806"},{"key":"e_1_2_7_67_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4002098"},{"key":"e_1_2_7_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2008.11.006"},{"issue":"49","key":"e_1_2_7_69_1","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0076-6879(05)04049-8","article-title":"Rapid purification of native dynamin I and colorimetric GTPase assay","volume":"404","author":"Quan A","year":"2005","journal-title":"Methods Enzymol"},{"key":"e_1_2_7_70_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm0002634"}],"container-title":["Traffic"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftra.12272","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/tra.12272","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T22:59:49Z","timestamp":1696201189000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/tra.12272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,9]]},"references-count":69,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["10.1111\/tra.12272"],"URL":"https:\/\/doi.org\/10.1111\/tra.12272","archive":["Portico"],"relation":{},"ISSN":["1398-9219","1600-0854"],"issn-type":[{"value":"1398-9219","type":"print"},{"value":"1600-0854","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,9]]}}}